Cargando…

Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan

Background: This study aimed to survey the attitudes toward COVID-19 vaccines and their acceptability among the Japanese public as soon as the United States Food and Drug Administration (FDA) authorized vaccines and their rollouts started around the world. Methods: An anonymous cross-sectional surve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiwen, Cai, Guoxi, Fan, Yi, Arima, Kazuhiko, Lin, Yulan, Wong, Liping, Zhang, Zhuo, Yamamoto, Taro, Morita, Kouichi, Yoshikawa, Akira, Lu, Yixiao, Aoyagi, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861095/
https://www.ncbi.nlm.nih.gov/pubmed/36680002
http://dx.doi.org/10.3390/vaccines11010157
_version_ 1784874755790209024
author Wu, Jiwen
Cai, Guoxi
Fan, Yi
Arima, Kazuhiko
Lin, Yulan
Wong, Liping
Zhang, Zhuo
Yamamoto, Taro
Morita, Kouichi
Yoshikawa, Akira
Lu, Yixiao
Aoyagi, Kiyoshi
author_facet Wu, Jiwen
Cai, Guoxi
Fan, Yi
Arima, Kazuhiko
Lin, Yulan
Wong, Liping
Zhang, Zhuo
Yamamoto, Taro
Morita, Kouichi
Yoshikawa, Akira
Lu, Yixiao
Aoyagi, Kiyoshi
author_sort Wu, Jiwen
collection PubMed
description Background: This study aimed to survey the attitudes toward COVID-19 vaccines and their acceptability among the Japanese public as soon as the United States Food and Drug Administration (FDA) authorized vaccines and their rollouts started around the world. Methods: An anonymous cross-sectional survey was conducted in Japan between 4 January and 5 March 2021. A questionnaire was administered to evaluate attitudes toward COVID-19 vaccines according to demographic characteristics, vaccine characteristics, and vaccine production. Results: A total of 1037 completed responses were received. More than half (63.5%) of the participants responded positively (extremely likely/likely) toward COVID-19 vaccines. The highest acceptance to be vaccinated was discovered among the youngest age group. As expected, participants who had never delayed acceptance or refused the vaccine in their history of vaccination had a significantly higher willingness to be vaccinated against COVID-19 (p < 0.001). Females (OR = 2.66, 95% CI: 1.99–3.58) and participants who had ever delayed acceptance or refuse the vaccine (OR = 3.49, 95% CI: 2.42–5.05) had higher odds of COVID-19 vaccine hesitancy. Participants with a postgraduate degree (OR = 0.64, 95% CI: 0.40–1.00) presented the highest willingness to be vaccinated against COVID-19. More than two-thirds (72.9%, 95% CI: 70.4%–75.8%) of the participants did not mind a booster dose required following primary vaccination. A total of 63.2% (95% CI: 60.0%–66.0%) of the participants only accepted a nearly 90% effective or above vaccine at preventing COVID-19. At the same, 86.4% (95% CI: 84.4%–88.4%) of the participants reported only accepting a vaccine with minor side effects. Conclusions: The moderate levels of COVID-19 vaccine acceptance found in the early phase of the pandemic demonstrate that it is important to improve the implementation of effective management for vaccine promotion and the acceptability of the vaccine to slow or delay transmission.
format Online
Article
Text
id pubmed-9861095
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98610952023-01-22 Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan Wu, Jiwen Cai, Guoxi Fan, Yi Arima, Kazuhiko Lin, Yulan Wong, Liping Zhang, Zhuo Yamamoto, Taro Morita, Kouichi Yoshikawa, Akira Lu, Yixiao Aoyagi, Kiyoshi Vaccines (Basel) Article Background: This study aimed to survey the attitudes toward COVID-19 vaccines and their acceptability among the Japanese public as soon as the United States Food and Drug Administration (FDA) authorized vaccines and their rollouts started around the world. Methods: An anonymous cross-sectional survey was conducted in Japan between 4 January and 5 March 2021. A questionnaire was administered to evaluate attitudes toward COVID-19 vaccines according to demographic characteristics, vaccine characteristics, and vaccine production. Results: A total of 1037 completed responses were received. More than half (63.5%) of the participants responded positively (extremely likely/likely) toward COVID-19 vaccines. The highest acceptance to be vaccinated was discovered among the youngest age group. As expected, participants who had never delayed acceptance or refused the vaccine in their history of vaccination had a significantly higher willingness to be vaccinated against COVID-19 (p < 0.001). Females (OR = 2.66, 95% CI: 1.99–3.58) and participants who had ever delayed acceptance or refuse the vaccine (OR = 3.49, 95% CI: 2.42–5.05) had higher odds of COVID-19 vaccine hesitancy. Participants with a postgraduate degree (OR = 0.64, 95% CI: 0.40–1.00) presented the highest willingness to be vaccinated against COVID-19. More than two-thirds (72.9%, 95% CI: 70.4%–75.8%) of the participants did not mind a booster dose required following primary vaccination. A total of 63.2% (95% CI: 60.0%–66.0%) of the participants only accepted a nearly 90% effective or above vaccine at preventing COVID-19. At the same, 86.4% (95% CI: 84.4%–88.4%) of the participants reported only accepting a vaccine with minor side effects. Conclusions: The moderate levels of COVID-19 vaccine acceptance found in the early phase of the pandemic demonstrate that it is important to improve the implementation of effective management for vaccine promotion and the acceptability of the vaccine to slow or delay transmission. MDPI 2023-01-11 /pmc/articles/PMC9861095/ /pubmed/36680002 http://dx.doi.org/10.3390/vaccines11010157 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wu, Jiwen
Cai, Guoxi
Fan, Yi
Arima, Kazuhiko
Lin, Yulan
Wong, Liping
Zhang, Zhuo
Yamamoto, Taro
Morita, Kouichi
Yoshikawa, Akira
Lu, Yixiao
Aoyagi, Kiyoshi
Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan
title Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan
title_full Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan
title_fullStr Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan
title_full_unstemmed Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan
title_short Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan
title_sort acceptance and preference for covid-19 vaccine among japanese residents at early stage of the epidemic in japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861095/
https://www.ncbi.nlm.nih.gov/pubmed/36680002
http://dx.doi.org/10.3390/vaccines11010157
work_keys_str_mv AT wujiwen acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT caiguoxi acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT fanyi acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT arimakazuhiko acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT linyulan acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT wongliping acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT zhangzhuo acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT yamamototaro acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT moritakouichi acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT yoshikawaakira acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT luyixiao acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan
AT aoyagikiyoshi acceptanceandpreferenceforcovid19vaccineamongjapaneseresidentsatearlystageoftheepidemicinjapan